Welcome

Manchester ECMC aims to expand and develop its experimental cancer medicine portfolio in areas such as radiotherapy, proteomics, metabolomics and imaging. The Centre has an active early phase (phase I/II) clinical trial programme in various cancer types, with related biomarkers studies, which aim to inform treatment decisions and monitor the effectiveness of therapies.